Terms: = Liver cancer AND MSI2, ENSG00000153944, 124540 AND Treatment
2 results:
1. Myofibroblast-Specific msi2 Knockout Inhibits HCC Progression in a Mouse Model.
Qu C; He L; Yao N; Li J; Jiang Y; Li B; Peng S; Hu K; Chen D; Chen G; Huang W; Cao M; Fan J; Yuan Y; Ye W; Hong J
Hepatology; 2021 Jul; 74(1):458-473. PubMed ID: 33609283
[TBL] [Abstract] [Full Text] [Related]
2. Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
He L; Zhou X; Qu C; Hu L; Tang Y; Zhang Q; Liang M; Hong J
J Cell Mol Med; 2014 Jan; 18(1):49-58. PubMed ID: 24305552
[TBL] [Abstract] [Full Text] [Related]
